Menu Menu

MYGN    Myriad Genetics Inc    899923    
Income Statement
Revenue 213,300,000
Net Income -22,100,000
Profit Margin -10.36%

Balance Sheet
Current Assets 293,200,000
Assets 1,081,300,000
Current Liabilities 154,300,000
Liabilities 349,600,000
Equity 731,700,000
Shares Out 90,820,000

Cash Flow Statement
Operating Cash Flow -15,300,000
Investing Cash Flow -6,000,000

Market Analysis
Market Cap 2,587,018,010
Price 12.39
BVPS 8.06
PB 1.54
EPS -1.80
PS 3.03
FCF -21,300,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/27 0.04
Apr May Jun
5/07 -0.01
Jul Aug Sep
8/06 0.05
Oct Nov Dec
11/04

Find a discrepancy? The most accurate way to find company fundamental data is to view MYGN documents filed with the SEC.


MYGN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: